EU OKs $4.9B Teva-Ratiopharm Deal, With Caveats
Teva Pharmaceutical Industries Ltd. has won the European Commission's blessing to proceed with its $4.93 billion purchase of German generic-drug manufacturer Ratiopharm GmbH by agreeing to a sell-off of assets in...To view the full article, register now.
Already a subscriber? Click here to view full article